Facebook Linkedin Mail Twitter Youtube
Facebook Linkedin Mail Twitter Youtube
    Latest

    Latest News

    Douglas Drachman named as next vice chair of American College of Cardiology’s Annual Scientific Session

    EACTS 2019: Leading cardiothoracic surgeon questions EXCEL trial’s conclusion

    Abiomed announces PROTECT III clinical data for protected PCI with Impella

    AccuCinch ventricular repair system associated with favourable safety profile at 30 days

    TCT 2019: Apixaban plus a P2Y12 inhibitor is the optimal strategy for AF with ACS and/or PCI

    CE mark granted to the Gore Cardioform ASD Occluder for the treatment of atrial septal defects

    Endotronix closes expanded series D financing round of US$70 million for Cordella

    TCT 2019: Resolute Onyx noninferior to BioFreedom in high bleeding risk patients treated with one-month DAPT

    TCT 2019: TAVI has sustained health status benefits over surgery for low-risk patients at one year, with similar five-year outcomes for intermediate-risk patients, unless via a transthoracic route

    TCT 2019: Benefits of complete revascularisation continue to accumulate over the long term

    TCT 2019: COAPT finds MitraClip safety and efficacy is maintained at three years, and is cost-effective

    TCT 2019: Acurate neo does not meet non-inferiority compared to Sapien 3

    TCT 2019: Safety and efficacy of Portico valve noninferior to FDA-approved TAVI systems

    TCT 2019: Aspirin withdrawal after three months of dual antiplatelet therapy reduces bleeding without an increase in ischaemic events among high-risk patients following PCI

    FDA approves Evolut PRO+

    Boston Scientific announces schedule of presentations at TCT 2019

    Corindus showcasing CorPath GRX system at TCT 2019

    Abbott starts trial to evaluate TriClip for percutaneous repair of tricuspid regurgitation

    merit-medical-radial-compression

    Merit Medical unveils PreludeSYNC EVO radial compression device

    ESC 2019: Registry study supports use of ICDs for primary prevention in patients with heart failure

    ESC 2019: Two-year findings of MITRA-FR continue to show no prognosis benefit with MitraClip

    ESC 2019: Ultrathin strut Orsiro better than thin strut Xience for STEMI patients

    ESC 2019: Left atrial appendage closure is non-inferior to NOACS for preventing major neurological, cardiovascular, and bleeding events

    complete-revascularisation

    ESC 2019: Complete revascularisation superior to culprit lesion-only PCI in STEMI and multivessel CAD irrespective of timing of intervention

    ESC 2019: Prasugrel bests ticagrelor for the management of acute coronary syndromes

    ESC 2019: Abiomed launches Impella SmartAssist platform

    Low-dose polypill could be used for primary prevention of cardiovascular events

    FARXIGA meets primary endpoint in Phase III DAPA-HF trial

    CeloNova appoints new president and CEO

    FDA approves new device to improve symptoms in patients with advanced heart failure

    FDA approves Sapien 3 Ultra, Sapien 3, and CoreValve for low-risk TAVI

    Announcing the TCT 2019 late-breaking trials and science

    wirion

    Cardiovascular Systems acquires Gardia Medical’s Wirion embolic protection system

    Transcatheter repair of tricuspid valves appears safe and effective when surgery is not an option

    Hormone therapy linked to heart fat and hard arteries

    SeQuent Please ReX drug-coated PTCA balloon catheter receives FDA breakthrough device designation

    xarelto rivaroxaban

    Rivaroxaban recommended by NICE for peripheral and coronary artery disease patients

    Age alone should not preclude TAVI in patients aged ≥90 years

    Unfilled prescriptions for PCSK9 inhibitors lead to higher rates of cardiovascular events

    Medtronic enters into AI partnership for stroke care

    TARGET BP I trial enrols its first patient

    Edwards Lifesciences to discontinue its self-expanding valve Centera

    Edwards Lifesciences issues urgent safety notice for Sapien 3 Ultra

    Fourth-generation MitraClip receives FDA approval

    Women with idiopathic intracranial hypertension at twice the risk of cardiovascular disease

    SAVR has lower mortality and MACCE than TAVI using first-generation devices in low- and intermediate-risk patients after five years

    Carillon Mitral Contour System reaches 1,000 implants for functional mitral regurgitation

    Medtronic announces global registry of HVAD thoracotomy implants

    FEops HEARTguide wins CSI Highlight of the Year Award

    Edwards Lifesciences issues an urgent field safety notice for Centera TAVI system

    MeRes100 BRS demonstrates sustained safety and efficacy

    Admedus’ announces favourable five-year outcomes for its CardioCel bioscaffold

    PASCAL poised to rival MitraClip for safety and efficacy

    NICE issues recommendations on insertion of cerebral protection devices during TAVI

    Zoll Medical acquires TherOx

    Patent granted to Valfix Medical for its percutaneous valve and replacement technology

    Robotic PCI company adds interventional cardiology experts to its medical advisory board

    Philips announces new advanced automation capabilities for its EPIQ CVx and EPIQ CVxi cardiac ultrasound systems

    India-designed Myval associated with no device-related mortality at one year

    Mentice and Siemens Healthineers aim to bring a virtual patient to the angio-suite

    Nearly 50% of treatment strategies would change with use of investigational HeartFlow planner

    DSM and SAT enter partnership to develop the first next-generation heart valve

    CMS’ update to coverage policy for TAVI provides greater flexibility for hospitals and providers

    New trial to compare Watchman FLX to direct oral anticoagulants

    US$170m funding for Acutus Medical

    SCAI document provides advice on cath labs’ financial viability

    TVT 2019: PASCAL system may be beneficial for managing tricuspid regurgitation

    TVT 2019: Purpose-designed temporary pacing guidewire has potential to make implantation of transcatheter heart valves “safer and more efficient”

    TVT 2019: TAVI is “preferred therapy” for low-risk patients

    Virtue sirolimus-eluting balloon set for commercial release as Terumo and Orchestra BioMed enter global strategic partnership

    Cardiologists can help to avert nuclear doomsday

    PCR statement on TAVI signals “paradigm shift” in treatment of severe symptomatic AS

    Early treatment with Helix system improves ejection fraction and symptoms

    Biotronik announces positive data for Magmaris

    FDA approves Cardioform ASD Occluder for the treatment of atrial septal defects

    American College of Cardiology names its first director of diversity and inclusion

    Philips launches IntraSight interventional applications platform

    Boston Scientific initiates trial comparing left atrial appendage closure to direct oral anticoagulants for stroke risk reduction post-AFib ablation

    Medtronic launches Telescope guide extension catheter

    EuroPCR 2019: VIVALL pilot study shows promise for safe use of Allegra heart valve in bioprostheses

    EuroPCR 2019; TRILUMINATE suggests TriClip is safe and effective

    EuroPCR 2019: PCR issues statement on edge-to-edge repair in heart failure management with secondary MR

    EuroPCR 2019: Renal denervation linked to reduction in subclinical atrial fibrillation

    EuroPCR 2019: Ultrathin stent demonstrates benefits in small vessels

    EuroPCR 2019: Consensus paper on intracoronary imaging focuses on acute coronary syndrome

    Diagnosing coronary stenosis with diastolic pressure ratio measurements is equivalent to using iFR

    ClearFlow announces positive trial results and inclusion in ERAS guideline recommendations for its PleuraFlow system

    Randal J Thomas looks to home-based cardiac rehabilitation

    USA needs to put greater emphasis on home-based cardiac rehabilitation

    Keith Dawkins appointed as chief medical officer at Shockwave Medical

    Avance steerable introducer given FDA 510(k) clearance

    Cordis expands its interventional cardiology portfolio with full US launch of radial products

    impella in preventing heart failure in stemi patients

    FDA approves extended duration of use for Impella 5.0 and Impella LD heart pumps

    Majority of cath labs feel burdens of PCI public reports outweigh benefits

    Less than half of vein graft interventions use embolic protection

    Triage STEMI patients for ICU after PCI based on reperfusion timing

    Vitros high-sensitivity troponin assay receives CE mark

    NeoChord raises additional financing to drive catheter‐based programme development

    Biotronik launches PK Papyrus covered coronary stent in the USA

    Virtue SEB given breakthrough device designation by FDA

    Bardy Diagnostics announces $35.5M funding injection

    Lotus Edge becomes third TAVI device on US market

    US FDA approve SSO2 Therapy for the management of myocardial infarction

    TAVI company Tioga Medical closes US$15M in series A financing

    PhaseBio receives FDA breakthrough therapy designation for PB2452 for the reversal of the antiplatelet activity of ticagrelor

    Targeted blood pressure management helps to reduce strokes in patients with HVAD

    CE mark for the FEops HEARTguide

    Comics may help patients to better understand coronary interventions

    Prevalence of multiple organ failure among cardiogenic shock patients has steadily increased

    ACC 2019: Less bleeding with one-month DAPT than standard therapy, with no increased ischaemia

    RADIANCE SOLO HTN finds greater blood pressure drop after renal denervation

    Alirocumab receives EC approval in established atherosclerotic cardiovascular disease

    Richard Kovacs assumes presidency of the American College of Cardiology

    ACC 2019: TAVI moves to the mainstream with new findings in low-risk patients

    CRT 2019: Evolut R superior to surgery at one year in intermediate-risk patients

    CRT 2019: Alert system is safe, quick, and has few complications

    MitraClip in moderate surgical risk patients

    MitraClip can be used to treat secondary mitral regurgitation in the USA

    Micro Interventional Devices enters strategic alliance with Oscor

    CardioCel 3D and VascuCel receive regulatory approval in Europe

    ACC to offer transcatheter valve certification to help hospitals implement best practices

    CE mark for Watchman FLX left atrial appendage closure device

    Scott Gottlieb resigns as head of US FDA

    CRT 2019: Peregrine catheter demonstrated 100% procedural success in post-market clinical trial

    CRT 2019: Early resorption and low complications demonstrated for Magmaris

    Innovative cardiovascular systems announce first use of its next-generation Emblok embolic protection system in European feasibility study

    Woman patient

    Myocardial infarction patients taken directly to heart centres have better long-term survival

    CRT 2019: Three-year data shows trend towards lower target vessel failure with Orsiro vs. Resolute Integrity and Synergy

    CRT 2019: US FDA approves resting full-cycle ratio for measuring severity of coronary artery blockages

    CX 2019 to host first-ever aortic and peripheral virtual reality live cases

    Polymer-free stents have similar performance profiles, except in diabetes

    Sapien 3 provides safe and satisfactory access via the transcarotid route

    MedAlliance granted “breakthrough device designation” from FDA for its sirolimus-coated balloon

    New Australian research and development partnership aims to innovate heart failure care

    American College of Cardiology to launch new journal dedicated to cardio-oncology

    Augmented reality surgical technology unveiled by Philips and Microsoft

    US physicians can now use Resolute to treat chronic total occlusions

    CE mark for R-One robotic-assisted solution for treating coronary diseases

    FDA approves Orsiro for use in the USA

    iVascular receives CE mark for Navitian microcatheter

    CE mark for PASCAL mitral valve repair system

    ACC to tackle patient, provider access to novel therapies

    Zenition

    Philips launches Zenition mobile C-arm platform

    Rehab programme after myocardial infarction helps to reduce death

    One in five US patients with atherosclerotic cardiovascular disease cannot pay their medical bills

    Long-term function of TAVI valves “is excellent”

    Leviticus Cardio and Jarvik Heart new fully implanted ventricular assist device

    London hospital provides first video consultation service for specialist care in England

    Less than a third of Americans known that cardiovascular disease is the biggest cause of death

    US FDA grant premarket approval to Manta vascular closure device

    First trial of in-heart micro device for left atrial pressure monitoring launched

    PreludeSync distal compression device now available globally

    Alvimedica announces CE mark for Cre8 Evo 2mm

    Registry data for Biotronik’s bioresorbable scaffold Magmaris supports its roll-out into clinical practice

    CE mark for cloud-based monitoring platform Impella Connect

    German NUB Status 1 designation for Neovasc Reducer renewed

    Editors-in-chief of major cardiovascular journals claim medical misinformation puts “lives at stake”

    The British Heart Foundation’s “Big Beat Challenge” is now accepting proposals

    SCAI

    Society for Cardiovascular Angiography and Interventions supports continued use of paclitaxel devices

    FDA IDE approval for safety and feasibility clinical trial of Cor Tricuspid ECM valve

    Vascular Dynamics names Martin Rothman chief medical officer

    Philips launces Azurion with FlexArm to aid image-guided procedures

    Positive results for LivaNova’s Perceval sutureless valve

    Abbott to acquire Cephea Valve Technologies

    shutdown

    US government shutdown disrupting FDA work

    Absence of known cardiovascular risk factors increases risk of sudden cardiac arrest in the setting of STEMI

    TAVI-induced bundle branch block and permanent pacemaker implantation are “not benign”

    New JACC publication reinforces valve of a coronary CTA + HeartFlow Analysis-guided pathway for diagnosing heart disease

    JenaValve Technology appoints John T Kilcoyne as chief executive officer

    Shockwave initiates US pivotal study for coronary intravascular lithotripsy

    Sleeping less than six hours a night may increase cardiovascular risk

    FDA approves world’s first device for treatment of premature babies and newborns with an opening in their hearts

    Boston Scientific, Edwards Lifesciences agree to global litigation settlement

    Does your insurance card matter when you have a heart attack?

    SCCT releases new guideline for use of computed tomography in TAVR procedure

    Patient recruitment reaches half-way point for global DAPT study

    First United States treatment with J-Valve TAVI device

    Increased BMI associated with significant increase in radiation exposure to physicians

    Meta-analysis shows FFR-guided PCI reduces myocardial infarction

    Unique therapeutic approach to treating uncontrolled hypertension receives US$77 million financing

    Sapien 3

    Sapien 3 Ultra receives FDA approval

    Internationally renowned cardiac surgeon joins University of Miami Health System

    FFRangio system receives US FDA clearance

    Boston Scientific exercises option to acquire Millipede

    First patients treated in United States with OrbusNeich Teleport Microcatheter

    More work needed to “untangle reasons” for gender gap in cardiovascular research

    The SYNTAX score should not be used to choose between CABG and PCI in diabetic patients with multivessel disease

    BioCardia submits 510(k) application to US FDA for its Avance steerable introducer for transseptal access to heart

    Merit releases Prelude IDeal hydrophilic sheath

    US District Court for the District of Delaware rules that Sapien 3 infringes a Boston Scientific patent

    Abiomed invests $15 million in Shockwave Medical

    Edwards Lifesciences to collaborate with Bay Labs to use AI software to improve detection of heart disease

    Woman patient

    Women wait for longer before calling for help when experiencing heart attack symptoms

    First-in-human “remote PCI” performed

    HeartFlow initiates PRECISE randomised clinical trial

    MitraClip in moderate surgical risk patients

    Draft NICE guidance supports use of percutaneous mitral valve repair

    paclitaxel

    Meta-analysis finds a higher risk of death in the long term when paclitaxel-coated devices are used in the leg

    Fantom bioresorbable scaffold implanted for the first time in Italy

    First implant of Pascal transcatheter mitral valve repair device performed in CLASP IID trial

    JenaValve receives FDA approval for expanded IDE enrolment in the treatment of patients with severe aortic stenosis and severe aortic regurgitation

    Personalised ultrasound scan showing atherosclerosis helps reduce cardiovascular risk

    Quidel receives CE mark for its TriageTrue high sensitivity troponin I test

    WeHealth by Servier and MobioSense form a partnership to develop digital portable myocardial infarction detection test

    American College of Cardiology New York Cardiovascular Symposium to bring together top cardiologists

    Presence of left bundle branch block significantly increases risk of pacemaker implantation after TAVI

    US FDA plan shakeup of its 510(k) clearance programme

    AHA 2018: Efficacy and safety of PCI with Ti-no coated bio-active stents presented

    Frail, older patients have 50% increased risk of bleeding during hospitalisation for myocardial infarction

    Sapien 3

    Launch of Sapien 3 Ultra hampered by Boston Scientific dispute

    Bay Labs and Northwestern Medicine enrol first patient in study using AI software to improve heart disease detection

    HeartFlow receives national reimbursement approval in Japan

    AHA 2018: Early invasive strategy without pretreatment significantly reduces recurrent ischaemic events in NSTE-ACS patients

    AHA 2018: Pilot study paves way for future evaluation of delaying reperfusion in STEMI patients

    US FDA approve new study of Medtronic’s Spyral renal denervation system

    Vivasure Medical announces launch of the PerQseal large bore closure device

    NeoChord announces US$25 Million Series D financing to accelerate development of two transcatheter chordal repair programmes

    AHA 2018: Study shows AliveCor phone app can effectively identify STEMI with nearly the same accuracy as a standard ECG

    First patient in Hong Kong receive treatment with coronary Orbital Atherectomy System

    Mark Schwartz become vice president of Clinical Affairs at BioCardia

    Cordis launches Mynx Control vascular closure device in the USA

    Fantom Encore launched onto market

    First US implantations of TriCinch Coil tricuspid valve repair system performed

    Colder air and reduced sunshine increases risk of myocardial infarction

    Atrial fibrillation related to PFO closure occurs early and is transient

    New drug formulation could help people undergoing heart surgery

    BioCardia and CellProThera to partner for clinical trial and marketing in Singapore of early stem cell therapy

    TCT 2018: Durable tricuspid regurgitation reduction with MitraClip

    TCT 2018: Severe prosthesis-patient mismatch linked to increased mortality at one year

    iVascular acquires 10% of NaviGate Cardiac Structures for US$10 million

    US FDA approve HeartMate 3 heart pump for advanced heart failure patients not eligible for a heart transplant

    Single-use, high-definition, miniature camera unveiled at Asia Pacific MedTech Forum 2018

    First patient enrolled in STTAR study of MIA—minimally invasive annuloplasty

    Caristo Diagnostics launched to commercialise new coronary CT image analysis technology

    Rivaroxaban gets FDA approval for treatment in CAD or PAD

    TMVI with Tiara valve may be safe and feasible for patients with prior aortic valve replacement

    Risk of death with unrecognised myocardial infarction equal to that with recognised myocardial infarction by 10 years

    FDA approve TSP Crosser transseptal access system

    Teleflex buys vascular closure company Essential Medical

    US trial of Edwards’ self-expanding Centera valve begins

    Only one third of patients in China receive cardiac rehabilitation

    TCT 2018: IVUS-guided PCI reduces target vessel failure in all-comers population

    Heart Research UK award £250,000 to researchers developing AI test for coronary heart disease

    Venus Medtech to buy cerebral protection device company Keystone Heart

    Megha Prasad selected as SCAI-Women in Innovations CHIP Fellowship

    TCT 2018: Orsiro continues to have lower rates of target lesion failure than Xience

    TCT 2018: One-year real-world results show Portico TAVI system reduces severe aortic stenosis

    TCT 2018: Longest-term data to date for CoreValve study show excellent valve durability out to five years

    TCT 2018: Use of Impella in cardiogenic shock patients associated with relative 24% increase in survival

    TCT 2018: LEADERS FREE II confirm favourable results for BioFreedom

    TCT 2018: Restore drug-coated balloon matches Resolute for small vessel lesions

    TCT 2018: FFRangio may provide a faster and easier approach to physiological assessment

    TCT 2018: Audience claps as COAPT shows MitraClip reduces HF hospitalisations

    TCT 2018: Lower rate of stent thrombosis with Resolute Onyx vs. Orsiro

    US FDA approve study of CoreValve Evolut in low-risk patients with bicuspid valves

    First patient enrolled in CARILLON pivotal trial

    PCR LV 2018: One-year results of VIVA confirm safety and efficacy of valve-in-valve procedures with CoreValve

    PCR LV 2018: Early discharge feasible for unselected TAVI patients

    PCR LV 2018: Favourable outcomes for next-generation Acurate neo2 TAVI system

    Onyx One Clear study starts in USA and Japan

    US FDA approves PK Papyrus stent for coronary perforations

    Two patients have been implanted with latest-generation of integrated ICE delivery system

    TCT 2018: Infraredx to present results of the LRP study

    TCT 2018: Corindus to feature the CorPath GRX system at conference

    SCAI mourns past president Joseph D Babb

    BTG buys Novate Medical

    Gore buys transcatheter mitral chordal repair technology

    First patients enrolled in trial of MobiusHD for drug-resistant hypertension

    ESC 2018: TMVI associated with “excellent outcomes” for valve-in-valve procedures

    SIS Medical to launch three innovative balloon catheters

    ESC 2018: More evidence that FFRCT is an effective approach for identifying patients who do not require further intervention

    Patients with new-onset atrial fibrillation after TAVI have highest risk of complications

    ESC 2018: First US FDA-approved study shows TAVI is safe for low-risk patients

    ESC 2018: Novel imaging biomarker can predict risk of cardiac mortality

    ESC 2018: Positive one-year results for Interatrial Shunt Device

    ESC 2018: All-cause mortality in cardiogenic shock multivessel PCI only increased during first 30 days

    ESC 2018: Ticagrelor monotherapy approach does not challenge current DAPT approach

    ESC 2018: No difference in MACE between drug-coated balloons and drug-eluting stents for de novo lesions in small vessels

    ESC 2018: Higher all-cause mortality with Orsiro at five years than with Xience

    ESC 2018: MitraClip makes “absolutely no difference” for the prognosis of secondary mitral valve regurgitation

    ESC 2018: Greater use of PCI for high SYNTAX score patients may explain higher rate of all-cause death with FFR in FUTURE

    Simultaneous TAVI and left atrial appendage closure is feasible

    ESC 2018: Non-atherosclerotic spontaneous coronary artery dissection predominantly affects young to middle-aged women

    ESC 2018: British Heart Foundation to provide £30m for innovation in heart disease

    Cerner and Duke Clinical Research Institute collaborate on new app for calculating cardiac risk

    ESC 2018: Siemens Healthineers showcase Magnetom Sola Cardiovascular Edition

    ESC 2018: Cardioskin launched

    Bayer announces new licensed indication for use of Xarelto in patients with coronary artery disease

    Twenty thousand patients have now been treated with RenalGuard therapy

    More than 100,000 people now know hands-only CPR thanks to AHA programme

    ClearFlow awarded group purchasing agreement for the chest drainage products category with Premier

    Philips launches new cardiac ultrasound solutions with anatomical intelligence

    Novel Ultraseal device is a feasible option for left atrial appendage closure

    Three-quarters of patients have sustained results at very long-term follow-up after percutaneous balloon mitral valve valvuloplasty

    “No option” for revascularisation in refractory angina does not mean never

    FDA sends letter warning about mortality and risks with the Syncardia TAH-t Companion 2 Driver

    Enrolment in FAST-FFR trial completed early

    Chronic kidney disease should not be a barrier to TAVI

    Re-evaluate use of anticoagulation in patients with atrial flutter

    Female acute myocardial infarction patients experience worse outcomes when treated by male physicians

    Patient enrolment in US early feasibility study of Everdur TAVI device initiated

    PRECLUDE study of Caisson TMVI system concludes

    Safety and efficacy results of REDUCE study published in International Journal of Cardiology

    Boston Scientific closes acquisition of Claret Medical

    New research links even low levels of air pollution with serious changes in the heart

    VisONE system for heart failure implanted for first time

    CE mark and US FDA approval for RadialSeal introducer kit

    Infraredx launches Makoto intravascular imaging system and Dualpro IVUS+NIRS catheter in Japan

    US FDA approval for SynchroMed II implantable system for treating pulmonary arterial hypertension

    Bayer receives positive CHMP opinion for rivaroxaban for patients with coronary artery disease

    On the fence result for initial CMS vote about TAVI volume requirements

    Abbott launches trial of its Tendyne transcatheter mitral valve implantation device

    Siemens Healthineers transforms care delivery with innovative new tests for faster diagnosis of myocardial infarction

    Benefit of epinephrine in out-of-hospital cardiac arrest countered by its neurologic effects

    Nitroglycerin may be a safe, effective, and economic approach of reducing risk of radial arterial occlusion

    “Remote PCI” successfully performed 100 miles away from the cath lab

    Advance CS coronary sinus infusion catheter used for the first time

    Boston Scientific to buy cerebral protection system company

    Reva’s Fantom scaffold is now being distributed in Italy

    Cardiovascular Systems signs international distribution agreement with OrbusNeich

    Societies launch joint report on TAVI

    Creavo launches largest US study of its kind

    US FDA clearance for TEECAD system for aiding transoesophageal echocardiography

    MitraClip in moderate surgical risk patients

    Next-generation of MitraClip approved for use in the USA

    Consider the transaortic approach when faced with difficult iliofemoral anatomy

    Malnourished patients have a three-fold risk of mortality after aortic valve replacement

    Funding for Neptune left ventricular assist device

    CPT code for CathWorks’ 3D FFRangio wire free system

    Otsuka Medical Devices, Otsuak Holdings, and ReCor Medical to merge

    New way to regenerate hearts after myocardial infarction identified

    HeartWare HVAD system receives US FDA approval

    First-in-human implant of BeGrow stent performed in 24-day old baby

    Leaflet thrombosis is not a predictor of stroke or all-cause mortality in the medium term

    Corwave announces issuance of US Patent Covering its implantable left ventricular assist device leveraging the wave membrane technology

    Cardiac hybrid imaging is an effective tool for predicting myocardial infarction

    FDA approves RADIANCE-II study of Paradise ultrasound denervation system

    Endotronix joins AHA’s Center for Health Technology & Innovation to broaden the use of guideline-based care for heart failure patients

    Lexington Biosciences concludes initial HeartSentry clinical study

    PERT Consortium and BTG form strategic partnership

    Largest insurer in USA now covers HeartFlow Analysis

    AorTech sign development agreement with Vascular Flow Technologies

    ACC’s ACTION registry to become Chest Pain—MI Registry

    TVT 2018: Tiara TMVI device featured in live case

    Novel “smart stent” can tell physicians when restenosis is occurring

    Carotid disease is not a risk factor for stroke or death in TAVI patients

    TVT 2018: Positive results for Manta large bore closure device

    One in five UK doctors say under staffing has affected patient safety

    Implantation of JenaValve successful in initial patients enrolled in CE mark study

    Bisexual men have more risk factors for cardiovascular disease

    Physicians are more willing to tolerate uncertainty about coronary artery disease testing if risk of malpractice is less

    Advantage of guided de-escalation of dual antiplatelet therapy seen in younger patients

    First patient enrolled in phase II of REFLECT study of TriGuard 3

    US FDA approve EchoMD AutoEF software for calculating left ventricular ejection fraction

    Caladrius receives FDA regenerative medicine advanced therapy designation for its CD34+ Cell therapy for refractory angina

    EuroPCR 2018: Study indicates “almost perfect agreement” between CT angiography and conventional angiography for revascularisation decisions

    EuroPCR 2018: Both immediate and delayed approaches seem to work for transient STEMI patients

    Combination of high-sensitive C-reactive protein with logistic EuroSCORE improves risk stratification in TAVI patients

    Consider patients’ risk of ischaemic stroke when choosing antiplatelet therapies after PCI

    EuroPCR 2018: Low incidence of cardiovascular mortality with Centera self-expanding valve at one year

    Corindus receives Japanese PMDA approval for its CorPath GRX system

    EuroPCR 2018: No significant difference in bioprosthetic valve dysfunction between surgical and TAVI devices at six years

    Europe braces for harder times in medical device innovation while US FDA eases regulations

    EuroPCR 2018: Real-world data confirm trial outcomes for Sapien 3

    EuroPCR 2018: FFR-guided PCI reduces spontaneous myocardial infarction

    Looks do matter—patients claim what doctors wear is important

    BCS 2018: Novel blood test for myocardial infarction could be used in portable device

    Biomerics acquires FutureMatrix Interventional

    US FDA classifies HeartWare HVAD power issues as a Class I recall

    EuroPCR 2018: New ORBITA analysis finds iFR/FFR values do not predict impact of PCI on exercise time

    EuroPCR 2018: Data confirms long-term safety and efficacy of Angiolite drug-eluting stent

    EuroPCR 2018: PiCSO therapy reduces infarct size in acute myocardial infarction patients

    The European Commission authorise use of evolocumab to reduce risk of myocardial infarction in patients with established cardiovascular disease

    EuroPCR 2018: Interim nine-month results for Magnitude presented

    Positive clinical results from eCOBRA study

    EuroPCR 2018: One- to two-year landmark analysis shows significantly lower target lesion failure with Orsiro vs. Resolute Integrity

    EuroPCR 2018: Strong early vessel healing with Resolute Onyx in one-month DAPT study

    EuroPCR 2018: DIAB8 randomised study to compare Cre8 Evo with everolimus-eluting stents in diabetic patients

    Xience Sierra approved for use in USA

    EuroPCR 2018: Further evidence for safety and efficacy of Magmaris bioresorbable scaffold

    EuroPCR 2018: Positive data for renal denervation reignites interest in field

    EuroPCR 2018: Two studies provide support for HeartFlow Analysis

    Intravascular Lithotripsy for coronary artery disease launched in Europe

    “Excellent valvular function” with NaviGate’s GATE tricuspid valved stent at one year

    Enrolment of US early feasibility study of AccuCinch system for left ventricular repair expanded

    EuroPCR 2018: Boston Scientific outlines its key presentations

    First patient treated in first-in-man study of ChordArt mitral valve repair system

    Use of Resolute Onyx to be explored for the treatment of bifurcation lesions

    EuroPCR 2018: First-in-human study of Leaflex Performer for aortic stenosis initiated

    Signal that left radial access reduces the risk of PCI-related stroke

    CoreValve shows “favourable performance” at long-term follow-up

    Cardiac Dimensions appoints Matthew Stark as vice president of Clinical and Regulatory Affairs

    Japan’s Ministry of Health Labour and Welfare grants national reimbursement for Xience Sierra

    Only 16% of patients participate in a formal exercise programme after cardiac hospitalisation

    Cardioband becomes first-ever transcatheter tricuspid system to receive the CE mark

    SCAI 2018: David A Cox becomes Society’s new president

    Non-emergent, uncomplicated target lesion revascularisation significantly increases mortality

    TMVI in inoperable patients is feasible but mortality high at one year

    Terumo receives CE mark for Ultimaster Tansei drug-eluting stent

    TAVI is increasingly seen as the preferred approach for aortic valve replacement in CABG patients

    Boston Scientific successfully opposes Edwards Lifesciences Corporation’s European patent EP 2,399,550 (550)

    CE mark for HeartStitch’s transapical access and closure device

    Medtronic appoints Laura Mauri as vice president, Global Clinical Research & Analytics

    Women are still less likely to receive high-intensity statin therapy after myocardial infarction

    Location of tricuspid regurgitation predicts procedural success of percutaneous edge-to-edge repair

    A third of patients do not disclose their use of complementary therapy to physicians

    GUIDE-HF trial to evaluate whether CardioMEMS can improve survival and quality of life for people with NYHA Class II–IV heart failure

    Abiomed receives FDA approval for Impella CP with SmartAssist and Optical Sensor

    US FDA approves Cardioform septal occluder for PFO closure to prevent recurrent ischaemic stroke

    New trial of Symplicity Spyral approved

    Study of next-generation JenaValve device completes enrolment

    CIT 2018: BIOFLOW-VI confirms non-inferiority of Orsiro to Xience

    Enrolment complete in CT imaging substudy of leaflet mobility with Sapien 3 in low-risk patients

    First two patients enrolled in early feasibility study of second-generation Colibri valve

    UK Court of Appeal dismisses Edwards Lifesciences’ appeal against Sapien 3 infringement ruling

    Rome hospital to participate in European DuraGraft registry

    More non-cardiac death explains higher rate of post-PCI mortality in females

    Evidence of substance abuse found in 10% of young myocardial infarction patients

    ACC 2018: Short-term DAPT after PCI in acute coronary syndrome patients is not safe

    ACC 2018: Morphologic characteristics may determine benefit of percutaneous PFO closure

    Enrolment complete in BIOSTEMI study

    ACC 2018: Using iFR over FFR saves US$896 per patient per year

    ACC 2018: Five-year data for CoreValve show strong haemodynamic performance

    FDA approves the world’s smallest mechanical heart valve

    Woman patient

    ACC 2018: Four-step protocol improves outcomes in STEMI patients and eliminates gender disparities

    ACC 2018: Alirocumab reduces cardiovascular events in high-risk patients

    ACC 2018: C Michael Valentine become new president of the American College of Cardiology

    Sapphire II PRO becomes US’s first and only 1mm coronary balloon

    HeartFlow enters into licensing agreement with Cedars-Sinai for AutoPlaque technology

    Cardiogenic shock patients would benefit the most from reducing contact-to-balloon time

    “Favourable” in-hospital outcomes for younger patients undergoing TAVI

    Myocardial infarction patients may benefit from having anxiety

    CE mark for 2.5mm Fantom Encore bioresorbable scaffold

    New “Corrie” app may reduce readmissions after myocardial infarction

    Following FDA approval, Resolute Onyx 2mm becomes smallest stent on US market

    FDA releases final rule on acceptance of data from clinical investigations for medical devices

    Edwards’ self-expanding Centera TAVI valve now on European market

    Short-term DAPT is feasible for patients undergoing percutaneous LAA closure

    Fifty US centres are now using Claret Medical’s Sentinel cerebral protection system

    Abiomed receives expanded FDA approve for high-risk PCI procedures

    First patient enrolled in trial reviewing 28-day DAPT with Xience

    LivaNova to buy TandemLife

    Patient enrolment at UK sites of European DuraGraft registry initiated

    American College of Cardiology expand programme to lower readmission rates after myocardial infarction

    Ticagrelor significantly reduces the risk of MACE in myocardial infraction patients with multivessel disease

    BioVentrix now has 2018 NUB Reimbursement Status 1 in Germany for its Revivent TC system

    ISET 2018: OPTALYSE PE trial reinforces safety and efficacy of EKOS therapy

    Stress response may be reason for link between traffic noise and cardiovascular disease

    Siemens Healthineers and Circle Cardiovascular Imaging announce joint development plan for MRI application products

    More than 185 million patients now have access to HeartFlow FFRct

    Depression significantly increases mortality after aortic valve replacement

    Laboratory-confirmed influenza significantly increases the risk of acute myocardial infarction

    Key interventional cardiologists come together to form medical advisory board for robotics company

    US FDA grants BioCardia IDE approval for the CardiAMP chronic myocardial ischaemia trial

    First patient enrolled in Tryton post-approval study

    Corindus Vascular Robotic to co-sponsor courses on transradial coronary interventions

    Telemark microcatheter receives US FDA approval

    Woman patient

    Patients who have an in-hospital cardiac arrest at the weekend continue to have worse outcomes

    Boston Scientific enters into an acquisition option agreement with Millipede

    Japanese Ministry of Health approve Biotronik’s Orsiro drug-eluting stent

    Prediabetes significantly increases risk of events after PCI

    Next-day discharge appears safe for TAVI patients without in-hospital complications

    Nearly 25% of chronic ischaemic heart disease patients dead or hospitalised in six months

    First US commercial implants of Elunir drug-eluting stent performed

    Mayo Clinic using robot-assisted PCI for preclinical study on “telestenting”

    First patient enrolled in OPTIMIZE study of Svelte drug-eluting stent integrated delivery system and rapid exchange platforms

    Second myocardial infarction twice as likely to occur non-culprit artery than in culprit artery

    First-in-human implantation of the Cordella pulmonary artery pressure sensor performed

    Acarix announces start of multicentre trial for handheld CADScor system

    Sixty-day follow-up for the MANTA US pivotal trial completed

    Miracor Medical raises €25M to support clinical and prepare commercial activities

    Recommendations for the use of embolic protection devices during saphenous vein graft intervention may need revising

    Modifying procedural technique during TAVI may lower radiation exposure to patients

    Promising results for RenalGuard in heart failure patients

    London’s Science Museum honours 50 years of heart transplants

    Health Care Service Corporation deem that FFRCT may be a “medically necessary” procedure for guiding coronary interventions

    Janssen seeks approval for rivaroxaban to be used to reduce cardiac events

    Apple and Stanford Medicine launch app-based arrhythmia study

    M Lewis Kinard appointed as executive vice president, general counsel and assistant corporate secretary of the AHA

    Philips acquires cloud-based population health management solution provider VitalHealth

    Edwards Lifesciences acquires Harpoon Medical

    Harpoon Medical acquired by Edwards

    ICI 2017: Novel transcatheter mitral valve wins Best Technology Parade Presentation

    Pollution may derail benefits of walking in older adults

    Global survey indicates that patients with type 2 diabetes underestimate their risk of cardiovascular disease

    “Vast majority” of young myocardial infarction patients do not meet criteria for statin therapy prior to event

    STEMI patients at highest risk are less likely to receive optimal medical therapy

    EpicHeart soft-robotic heart assist device wins innovation award

    TCT 2017: FAME 2 provides support for PCI in stable disease after ORBITA

    Evolocumab becomes first PCSK9 inhibitor to be approved for use in the USA to prevent myocardial infarction

    TCT 2017: Advances in device technology needed to improve outcomes with Absorb

    Report calls for US to prioritise health resources towards diagnosing and diseases like cardiovascular disease

    Elunir drug-eluting stent approved for use in the USA

    Inhaled Xenon plus hypothermia may reduce myocardial injury after an out-of-hospital-cardiac arrest

    China’s first human implantation of a retrievable TAVI device successfully completed

    Boston Scientific pushes back plans for commercialisation of Lotus Edge TAVI device

    US patients have had more preventive care for cardiovascular disease under the Affordable Care Act

    AHA 2017: Widely used approach for preventing renal complications after angiography does not provide benefit

    AHA 2017: Novel transcatheter therapy for heart failure shows promise in sham-controlled trial

    Creavo's Vitalscan

    Creavo wins two awards for its cardiac imaging device

    AHA 2017: Nutty eating habits may lower the risk of cardiovascular disease

    AHA 2017: First patients enrolled in trial of IASD system for heart failure

    Precommercialisation of Serpentis drug-eluting stent announced

    New study shows significant clinical workflow and staff experience benefits of Azurion image-guided therapy platform

    AHA 2017: Fun in the bedroom is unlikely to cause a sudden cardiac arrest

    Neovasc receive approval to initiate COSIRA-II IDE clinical trial

    TCT 2017: Sham-controlled trial raises doubts about benefit of angiography-guided PCI for stable angina

    TCT 2017: Study challenges recommendations on the management of cardiogenic shock

    MitraClip becomes first approved device for transcatheter mitral valve repair in Japan

    Centers for Medicare and Medicaid Services finalise a new technology ambulatory payment classification for HeartFlow

    TCT 2017: Elixir reveals new drug-eluting stent

    TCT 2017: Pooled analysis of Magmaris studies continue to show no instances of scaffold thrombosis at 12 months

    TCT 2017: Next-generation FFR system launched

    TCT 2017: No advantage with extending dual antiplatelet therapy beyond six months in STEMI patients

    TCT 2017: Fantom bioresorbable scaffold continues to show positive outcomes at two years

    TCT 2017: Two studies support feasibility of transcatheter mitral valve implantation

    TCT 2017: No role for bare metal stents to reduce duration of dual antiplatelet therapy in older patients

    Sapien 3

    TCT 2017: TAVI “should be the preferred strategy” for patients at intermediate-risk

    TCT 2017: New data for CoreValve Evolut further support its use in intermediate-risk patients  

    TCT 2017: Combo dual-therapy stent is non-inferior to Xience at one year

    Xience Sierra is now on European market

    TCT 2017: Data for novel cardiac imaging technology unveiled

    TCT 2017: AI-driven cardiac ultrasound company to give two presentations

    Woman patient

    First year after a myocardial infarction poses more risks for women

    US FDA 510(k) clearance for its Nova Cross Extreme and Nova Cross BTK Micro catheter for support of guidewire access to discrete regions of the coronary and peripheral vasculature

    Cobra PzF nano-coated stent now being studied with 14-day DAPT in patients at high risk of bleeding

    Heart valve replacement surgery may not be a morning procedure

    Controlling blood pressure may help to prevent mitral regurgitation

    TCT 2017: Boston Scientific reveals presentations at conference

    Claret Medical closes on series C financing of US$14.5m

    First patient implanted with Intrepid TMVI device in APOLLO trial

    Second successful implant of minimally invasive annuloplasty system announced

    Myocardial infarction survivors more likely to use “emotion-focused” strategies to cope with stress

    “Neurocardiologists” could treat acute ischaemic stroke patients when a neurointerventionalist is not available

    Fantom bioresorbable scaffold implanted for first time in Switzerland

    TCT 2017: Elixir Medical to reveal “a game-changing metallic drug-eluting stent platform”

    Cardiology societies come together to provide new assessment options for subspecialities

    Coronary angiography after TAVI with a self-expanding valve is challenging but feasible

    Creavo Medical Technologies receives US FDA 510(k) approval for Vitalscan

    Relatively few chronic kidney disease patients require dialysis after TAVI

    US doctors urged to take action on gun violence

    First patient enrolled in Frontier IV clinical trial of PerQseal large arteriotomy closure technology

    TCT 2017: Alec Vahanian to receive the Master Clinical Operator award

    Study demonstrates feasibility and safety of RenalGuard of reducing risk of acute kidney injury in CABG patients

    CADScor system shown at the German Heart Days meeting

    Analysis of LAA closure devices reveals post-approval spike in safety events

    Pamela B Morris to be next American College of Cardiology scientific session vice chair

    Enrolment in BIOVITESSE trial of polymer-free coronary stent initiated

    Data for NobleStitch EL suture based closure system presented at CSI UCSF Congress

    Thomas F Lüscher becomes director of education, research and development at Royal Brompton & Harefield NHS Foundation Trust

    EACTS 2017: Vascular Graft Solutions to hold symposium on venous external support

    No significant differences in post TAVI outcomes between African Americans and Caucasians

    First patient enrolled in US arm of ALIVE pivotal clinical trial

    Essential Medical completes enrolment in US IDE trial of Manta

    First procedure performed in Rox Medical’s CONTROL HTN-2 clinical trial

    Missing out on breakfast may increase risk of atherosclerosis

    Sirolimus-coated balloon “may represent a new approach to treating in-stent restenosis”

    Woman patient

    Delayed diagnosis affects women’s treatment for heart disease

    BioCardia CardiAMP

    BioCardia phase III CardiAMP trial passes interim safety analysis

    Medtronic HeartWare HVAD approved for destination therapy

    Enrolment completed in US pivotal clinical study of Cardioform ASD Occluder

    PCR LV 2017: Refining implantation technique and device iterations may improve pacemaker rate seen with Lotus

    TherOx' SSO2

    US FDA accepts PMA application for TherOx’ SSO2

    US FDA approves coronary indication for ReFlow’s Wingman

    Spectranetics' Bridge

    FDA issues class I recall for Spectranetics’ Bridge occlusion balloon catheter

    Philippe Généreux appointed chief medical officer of Saranas

    New performance and quality measures for treating heart attack patients

    Optiflow arterial cannulae family launched onto the USA

    iVascular’s drug-eluting stent and drug-eluting balloon now available for sale in India

    American College of Cardiology says that reforms to US healthcare come at “expense of bipartisan negotiations”

    FORWARD PRO clinical study to evaluate longer term performance of CoreValve Evolut Pro

    FDA grants Abiomed pre-market approval for is Impella RP for right heart failure

    Direct stenting with drug-eluting stents may be associated with better outcomes

    Three studies support efficacy of PFO closure for reducing risk of recurrent stroke

    Cancer history influences treatment of myocardial infarction

    Creavo's Vitalscan

    Creavo’s Vitalscan “rule out” technology on show at EUSEM

    Toddler

    Re-interventions common in long-term Fontan procedure survivors

    Average age and income of US cardiologists on the rise

    CardiAMP Heart Failure trial to further evaluate use of regenerative therapy in heart failure patients

    Carag completes CE marking for its breakthrough Carag bioresorbable septal occluder

    FDA grants 510(k) clearance to Fysicon’s QMAPP haemodynamic monitoring system

    All-comers data indicate stroke-free survival is improved with Sentinel embolic protection device

    New meta-analysis finds RenalGuard reduces all-cause mortality in patients undergoing cardiac interventions

    Edwards Lifesciences’ Alterra adaptive prestent device used for first time to treat a malformed pulmonary valve

    TCT 2017: Cardiovascular Research Foundation announces late-breaking trials and first-report investigations

    Neovasc provides Tiara clinical update

    First patient enrolled in PRECISION GRX registry

    New literature review highlights that Perceval sutureless aortic valve is safe

    Court of Dusseldorf grants Alvimedica an injunction against A B Handels GmBH

    ESC 2017: Post-TAVI clinical leaflet thrombosis is “infrequently reported” but is a serious adverse event

    ESC 2017: More evidence that supplemental oxygen in normoxic patients with suspected myocardial infarction does not provide benefit

    “Low commercial sales” prompt Abbott to pull the plug on selling Absorb

    Minimally invasive annuloplasty has been used to successfully perform bicuspidisation of a tricuspid valve

    ESC 2017: CABG is the “preferred strategy” for multivessel revascularisation in patients with type 1 diabetes

    ProtEmbo cerebral protection system used for first time

    American societies come together to publish appropriate use criteria for valvular heart disease

    Abbott’s Full MagLev HeartMate 3 LVAD receives FDA approval

    ESC 2017: MobiusHD implant shown to reduce resistant hypertension

    A 52mm tricuspid valve successfully implanted into a transplanted heart

    ESC 2017: Rivaroxaban significantly lowers risk of stroke, cardiovascular death, and myocardial infarction in patients with coronary artery disease

    Global agreement between Philips and HeartFlow announced

    ESC 2017: Subanalysis of PEGASUS shows ticagrelor reduces cardiovascular death by 29% in patients with prior myocardial infarction

    US trial to evaluate safety and efficacy of Amplatzer for patent ductus arteriosus

    ESC 2017: Hexacath’s titanium-nitride-oxide coated stent matches Boston Scientific’s Synergy for acute coronary syndrome

    ESC 2017: Best-practice PCI outperforms conventional PCI in patients with de novo three-vessel disease

    ESC 2017: SPYRAL HTN-OFF MED provides “proof of principle” that renal denervation works

    ESC 2017: Significantly lower event rates with Orsiro than with Xience

    ESC 2017: Case builds for dropping aspirin from triple therapy in atrial fibrillation patients post PCI

    US FDA clears Biostable’s HAART 200 bicuspid aortic valve repair annuloplasty device

    “Singheart” offers step towards heart regeneration

    Woman patient

    Heart failure patient and clinician risk perceptions differ drastically

    Medtronic to undertake global randomised clinical trial of one-month DAPT in Resolute Onyx patients

    HeartFlow FFRct Analysis receives four Blue Cross Shield endorsements

    Marijuana use associated with three-fold risk of death from hypertension

    LivaNova’s Perceval sutureless valve awarded Centers for Medicare and Medicaid add-on payment

    Social inequality may impact adult cardiovascular risk before birth

    Novel mitral regurgitation therapy featured in Innovation Summit at Cardiovascular Innovations

    Medtronic’s Avalus pericardial valve receives CE mark and FDA approval

    SHS invests in heart valve-repair start-up CoreMedic

    Pneumonia or sepsis increases risk of cardiovascular disease in first year by six fold

    Absorb prompts Boston Scientific to rethink its bioresorbable scaffold programme

    Keystone Heart accelerate trials for third-generation of its TriGuard device

    CE mark for CoreValve Evolut Pro

    Merit Medical partners with world-renown interventional cardiologist to deliver transradial course

    2 Heart Research UK funds UCL research to improve baby congenital heart disease diagnosis

    New study to evaluate safety of three-month DAPT with Xience in high bleeding risk patients

    American College of Cardiology says it opposes US healthcare reform

    Roxwood Medical announces agreement with Abbott for distribution of products in USA

    French doctors revise emergency plans to better deal with terrorism

    New PET-CT scan improves detection of sarcoidosis secondary to cardiac

    Millipede 50mm annuloplasty ring used in first cases

    European Medicines Agency issues positive opinion for rivaroxaban

    4C Medical receives over US$8 million financing for transcatheter mitral regurgitation treatment

    Black people do not have a higher rate of mortality one year after PCI

    Orodispersible tablets of ticagrelor now available in the UK

    Health Canada approves a high-dose bolus regimen of tirofiban

    Philips adds to list of recent acquisitions by buying TomTec

    Some plant-based diets associated with higher risk of heart disease

    Embolic protection device company raises US$5million in series B financing for advanced device development and initiation of US clinical activities

    First myocardial infarction more likely to be fatal in black people

    Cardiovascular drugs behind almost a quarter of medication error-related serious medical outcomes

    Meta-Analysis compares the safety and efficacy of S-DAPT and L-DAPT at two years

    GE Healthcare and HeartFlow announce global collaboration

    Sildenafil-coated stent may help prevent blood clots and restenosis

    Radical changes required to ensure US women receive optimal healthcare

    CoreValve Evolut can be used to treat intermediate-risk patients in the USA

    Essential Frailty Toolset may be best assessment of frailty for aortic stenosis patients

    Medtronic releases Resolute Onyx drug-eluting stent in Japan

    AMA issues unique Category III Current Procedural Terminology codes for HeartFlow FFRct

    FDA approve “first-in-class” resilient surgical valve

    First German order for Acarix’ CADScore system

    Unique 3D-printed heart valves could reduce TAVI paravalvular leakage rates

    Shingles associated with stroke and heart attack

    NHS hospital failed to comply with UK law when it gave data to Google DeepMind

    CSI 2017: Global postmarket surveillance study to explore use of LAmbre LAA closure system

    Europace 2017: Breast implants may lead to false heart attack diagnosis

    Obamacare health insurance expansion linked to fewer cardiac arrests

    Further data to support use of new-generation drug-eluting stents in women

    Nearly one in 10 US TAVI procedures is off label but results seem acceptable

    New hybrid operating room at Getinge Experience Center in Germany

    Haemodynamic support with Impella 2.5 heart pump significantly improves survival when initiated prior to PCI

    First European patient enrolled in study of percutaneous tricuspid repair system

    Philips to acquire Spectranetics “to accelerate expansion” in its image-guided therapy devices

    EuroPCR 2017: Study provides “first step” towards showing long-term durability of TAVI devices

    Childhood asthma may lead to thickening of left ventricle in adulthood

    Teleflex’s Vascular Solutions issues recall of Venture catheters

    Phase III Novartis study shows canakinumab reduces cardiovascular risk in heart attack survivors

    EuroPCR 2017: No risk factor identified for early stroke events in SURTAVI trial

    Nearly half of US women unaware that heart disease is their primary killer

    Negative late lumen loss at 24 months for TriReme Chocolate Heart

    Study confirms that volume matters for achieving lower in-hospital mortality after TAVI

    Italian boy becomes youngest patient bridged to transplant with the SynCardia Total Artificial Heart

    EuroPCR 2017: Switching to clopidogrel after one month reduces bleeding without increasing ischaemic events

    UK public health groups launch “Everyday Interactions” toolkit to measure professionals’ public health impact

    US FDA grants clearance to FlowGlide technology from ClearFlow

    Improving processes and outcome performance measures may be more be relevant than “arbitrary” PCI operator volume recommendations

    EuroPCR 2017: Greater risks with standard approach of dual antiplatelet therapy after TAVI

    German court awards Edwards Lifesciences co-entitlement of Neovasc’s Tiara patent application

    TVT 2017: Presentation showcases safety of Tempo temporary pacing lead

    Non-invasive approach could be used to improve valve opening functioning of biosprosthetic valves

    Venus Medtech buys InterValve

    US centres of TAVI excellence start to use newly approved Sentinel device

    ESC calls for sex-specific drug dosages of cardiovascular medication

    Risk of bleeding with aspirin in patients older than 75 is higher than thought

    EuroPCR 2017: Safety of deferring stenting in acute coronary syndrome patients is OK but could improve

    Survival benefit of early intervention in non-STEMI patients is independent of other factors

    Dose-tracking system reduces radiation exposure to patients during PCI

    HLT’s TAVI system implanted in first US patients

    OrbusNeich announces FDA clearance and launch of coronary dilatation catheters

    Sapien 3 receives expanded FDA indication for valve-in-valve procedures

    Sentinel becomes first cerebral protection device to receive FDA approval

    First procedures using Edward Lifesciences’ Inspiris Resilia aortic valve take place

    Pioneer Plus catheter re-entry device with intravascular ultrasound guidance relaunched

    EuroPCR 2017: Micell Technologies’ MiStent non-inferior to Abbot Xience in all-comers RCT

    Michael Buck named HeartFlow executive vice president and chief commercial officer

    Ultra-sensitive cardiac troponin test using Single Molecule Counting technology receives CE mark

    Award-wining system could be used to inform future surgeons about procedural details

    US FDA clears Stroke2prevent’s A-View balloon catheter

    Statins associated with improved heart structure and function

    Halting methamphetamine abuse can reverse related heart damage

    Diesel pollution linked to structural and functional heart damage

    First Revivent TC ventricular enhancement procedure for ischaemic cardiomyopathy performed

    Transendocardial delivery results in greater myocardial stem cell therapy retention

    EuroPCR 2017: Study finds no association between implantation technique and risk of scaffold thrombosis

    EuroPCR 2017: Head-to-head study validates consistent performance of FFR microcatheter

    EuroPCR 2017: No stent thrombosis with Resolute Onyx drug-eluting stent 2mm

    EuroPCR 2017: Excellent early outcomes for Edwards Lifesciences’ self-expanding valve

    EuroPCR 2017: Low risk of scaffold thrombosis with Magmaris

    Positive results for Gore’s PFO closure device

    EuroPCR 2017: Lotus TAVI device has superior efficacy to CoreValve at one year

    EuroPCR 2017: Teleflex introduce new Arrow AC3 Optimus intra-aortic balloon pump

    No difference in rate of adverse cardiovascular events when comparing anticoagulants

    EuroPCR 2017: ABSORB China and ABSORB show both comparable safety and efficacy to Xience at three years.

    SCAI 2017: New data from PLATINUM Diversity study provide further insight into under-served populations

    Boston Scientific closes Symetis acquisition

    EuroPCR 2017: Excellent clinical outcomes for Medtronic’s CoreValve and Evolut systems in routine practice

    Abiomed introduces third generation Impella CP heart pumps at SCAI 2017

    Boston Scientific to present REPRISE III and EWOLUTION data at EuroPCR

    NaviGate Cardiac Structures reports first heterotopic transcatheter Gate tricuspid valved stent successful implantation

    Large nuclear cardiology laboratory slashes radiation dose by 60% in eight years

    Reduced baseline left ventricular function may explain female survival benefit after TAVI

    GE Healthcare receives FDA indication approval for Visipaque injection for use with coronary CT angiography

    LivaNova acquires Caisson Interventional

    Risk-adjusted 30-day readmission rates are not associated with in-hospital quality of care

    Daiichi Sankyo initiates ENVISAGE-TAVI AF study to investigate once-daily edoxaban in atrial fibrillation undergoing TAVI

    Teleflex receives FDA 510(k) Clearance for its Arrow AC3 Optimus intra-aortic balloon pump

    Patient enrolled in STEMI DTU feasibility study

    Multicentre study demonstrates 3D Echo image analysis with Philips’ HeartModelA.I. is accurate and reproducible

    New data reaffirms value of Perceval for aortic valve replacement in aortic stenosis patients

    FDA approves Medtronic’s Resolute Onyx drug-eluting stent

    Non-O blood groups associated with higher risk of heart attack

    US FDA designates Medtronic HVAD system controller field action as class I recall

    Meta-analysis supports transaortic approach in TAVI

    High HbA1c levels after coronary intervention may predict risk of adverse events

    Absorb GTS to be restricted to registry use only in Europe

    First patient enrolled in new study of abbreviated DAPT post-stent in high bleeding risk patients

    Cordis granted CE mark for Railway sheathless access system

    LATERAL study offers positive overall results for Medtronic HVAD

    Microport TARGET AC three-month sub-study results to be presented at EuroPCR

    Occlutech obtains CE mark for its Perimembranous ventricular septal defect occluder

    Medtronic ENDURANCE Supplemental trial of HVAD fails to meet primary endpoint

    First patients enrolled in HLT’s Meridian transcatheter aortic valve feasibility study

    CE mark granted to NVT for Allegra transcatheter aortic valve

    Reva receives CE mark for Fantom drug-eluting scaffold

    Insomnia associated with increased risk of heart attack and stroke

    Armetheon to merge with Espero Pharmaceuticals

    Boston Scientific agrees to acquire Symetis

    SynCardia to honour eight total artificial heart hospitals during ISHLT

    Magnesium 1,000 programme reveals high deployment success for Biotronik’s Magmaris scaffold

    Cardiovascular Systems enrols first subject in ECLIPSE coronary clinical trial

    iVascular Capturer 7F granted CE mark

    Fantom II trial to include more complex cases

    First US commercial case performed using Tryton Side branch stent

    ACC 2017: Meta-analysis supports use of RenalGuard in cardiovascular Interventional procedures

    ACC 2017: FDA approves launch of CoreValve Evolut Pro

    Toshiba Medical’s AplioTM i900 cardiovascular ultrasound receives US FDA clearance

    Siemens Healthineers and HeartFlow to integrate CT and FFRct Analysis technology

    EBBINGHAUS trial shows non-inferiority of evolocumab for cognitive function in cardiovascular group

    RaySafe unveils new real-time dosimeter

    ACC 2017: Positive final results from ORION-1 phase II study of inclisiran

    ACC 2017: TAVI Linked with bleeding in the brain and neurological impairment

    BIOFLOW-IV confirms non-inferiority of Biotronik’s Orsiro in Japan

    ACC 2017: Embol-X and CardioGard do not reduce number of brain lesions, but may affect lesion size

    TAVI may benefit certain heart valve patients, update society guidelines say

    ACC 2017: “iFR may be the new standard” of physiological assessment of coronary lesions

    ACC 2017: Indigenous South American group has healthiest arteries ever studied

    ACC 2017: Acarix trial finds 97% negative predictive value for CADScor system coronary artery disease test

    ACC 2017: Mary Norine Walsh assumes American College of Cardiology presidency

    ACC 2017: Wrist-worn heart rate monitors less accurate than standard chest strap

    Coffee shops and cash machines ideal locations for lifesaving automated external defibrillators

    ACC 2017: Researchers sound alarm over Zika’s potentially harmful effects on heart

    ACC 2017: CardioMEMS HF system effective in reducing heart failure hospitalisations and cost of care

    ACC 2017: More hospitalisations & deaths for US heart failure patients in winter

    ACC 2017: PCSK9 inhibitor evolocumab significantly reduces the risk of cardiovascular events

    ACC 2017: Two-year rate of target lesion failure significantly higher with Absorb

    ACC 2017: No significant differences in two-year morality between bicuspid and tricuspid aortic stenosis patients undergoing TAVI

    ACC 2017: CoreValve non-inferior to surgery in intermediate-risk patients

    “Excellent early patency rates” for VEST device

    New “smART” kit for radial access launched

    Innovative Cardiovascular Solutions announces successful first use of its Emblok embolic protection system

    Five-fold increase in mortality in acute cardiac patients with delirium

    Early hospital discharge after TAVI less likely in women

    “Simple five-item risk score” could be used to predict bleeding risk associated with dual antiplatelet therapy

    Brian Brogie names as new vice president of manufacturing and facilities at SynCardia

    Melody pulmonary heart valve receives FDA approval for valve-in-valve use

    New research indicates “harmless” painkillers are associated with an increased risk of cardiac arrest

    Study indicates that Impella heart pump reduces acute kidney injury during high-risk PCI

    American College of Cardiology update appropriate use criteria for performing coronary revascularisation in patients with stable disease

    MR Solutions introduces 9.4T preclinical MRI imaging solution to cardiovascular sector

    Clinical trial rules should protect patients and results not operational details, says ESC

    Sapien 3

    UK Patents Court makes initial decision on Edwards Sapien 3 and Boston Scientific’s patents

    Illumina study completes enrolment

    FDA grants approval to Tryton for side-branch stent

    Screening for heart disease may lead to prevention, better treatments

    Daiichi Sankyo begins ENTRUST-AF PCI study of once-daily edoxaban

    US FDA grants 510(k) clearance to Teleflex for TrapLiner catheter

    Second successful annuloplasty performed using Micro Interventional Devices minimally invasive technology

    LivaNova to delist from London Stock Exchange

    First patient treated with CardiAmp cell therapy for ischaemic heart failure in Phase III trial

    Few heart attack survivors get recommended physical activity

    Elsevier announces the launch of Case: Cardiovascular Imaging Case Reports

    Physical activity may be more important than BMI for cardiovascular disease risk

    Corindus Vascular Robotics announces private placement for US$45 million

    Martha Goldberg Aronson joins Cardiovascular Systems board of directors

    Researchers urge physicians to discuss herbal medication use with heart disease patients

    Following dietary recommendations leads to modest heart health improvements

    Increased physical activity, lower BMI may lower heart failure risk

    European Society of Cardiology publishes special collection on eHealth revolution

    RenalGuard significantly reduces risk of contrast-induced acute kidney injury in high-risk patients undergoing interventional procedures

    Cobra PzF stent approved for commercial use in the USA

    Valve replacement may better than vavluloplasty for aortic stenosis patients with end-stage renal disease

    “No-touch” CABG reduces postoperative stroke and short-term mortality

    BTG’s EKOS control unit 4.0 receives FDA 510(K) clearance

    FDA advisory panel recommend de novo approval of Sentinel cerebral protection system

    Philips launch next-generation, image-guided therapy platform to enhance patient care and optimise lab productivity

    Transradial PCI reduces costs

    Locking mechanism problems prompt Boston Scientific to recall all ranges of its Louts TAVI device

    Teleflex completes acquisition of Vascular Solutions

    Cardiovascular Systems Micro Crown sustains high freedom from major adverse events at one year

    PCI does not confer mortality benefit for diabetic patients with chronic total occlusions

    First patient enrolled in the US LEADERS FREE II trial of BioFreedom

    FDA approves Biotronik’s Pro-Kinetic Energy bare metal stent

    Physicians may be overlooking patients’ desire to avoid dual antiplatelet therapy drawbacks

    Intensive blood pressure control could prevent 100,000 deaths each year

    SentreHEART Lariat and Eclipse receive reimbursement renewal in Germany

    Symetis acquires Middle Peak Medical

    Medtronic launches Impact education and development programme in Europe, Middle East & Africa

    NICE recommends HeartFlow FFRct Analysis to aid the determination of stable chest pain cause

    Plethysmography test predicts risk for cardiovascular disease

    Chinese air pollution linked to respiratory and cardiovascular deaths

    Medtronic releases DxTerity diagnostic catheters and transradial approach tool

    First commercial procedures performed with Corindus CorPath GRX system

    US FDA agrees to 1000-patient pivotal trial of Armetheon’s tecarfarin

    COMPASS study of rivaroxaban to end early for efficacy

    Cancer drug promotes regeneration of damaged heart tissue

    US FDA grants Fast Track designation to Angionetics’ Generx coronary heart disease gene therapy

    Study demonstrates sustained benefit of endovascular intervention in patients with lower extremity peripheral artery disease

    New guidelines released to improve stroke reporting following cardiac procedures

    Veryan Medical receives £13.5m further funding

    Evolocumab significantly reduces risk of cardiovascular events

    Edwards Lifesciences halts enrolment in Cardiaq trial

    Patient enrolment begins in European Somahlution DuraGraft registry

    “Telestenting” is possible with robotic PCI

    Meta-analysis indicates embolic protection does reduce stroke after TAVI

    Northwestern Memorial Hospital ranked best in USA for heart attack, stroke and heart failure survival

    Latest statistics show heart failure on the rise

    Frances Dea named new SCAI executive director

    Edwards Lifesciences completes acquisition of Valtech Cardio

    Positive results for heart surgery in elderly aortic stenosis patients

    DAPT

    Terumo completes acquisition of vascular closure business and other assets of Abbott and St Jude Medical

    Next-generation troponin T test from Roche cleared by US FDA

    Left atrial appendage thrombus may increase the risk of stroke after TAVI

    Homemade pelvic drape significantly reduces radiation exposure to the operator during transradial coronary interventions

    Alvimedica receives CE mark for amphilimus-eluting Cre8 EVO stent

    Medtronic receives CE mark for 34mm size CoreValve Evolut R

    TAVI company Direct Flow Medical closes after failing to secure funding

    Robert Califf to resign as US FDA commissioner

    Clínica Universidad de Navarra implants Spain’s first SynCardia Total Artificial Heart

    Researchers discover mechanism linking stress to heart disease

    JACC: Cardiovascular Imaging also to get a new editor-in-chief

    Boston Scientific may have resolved issue with Lotus Edge device

    Enrolment completed for ACIST-FFR multicentre study

    David J Moliterno to become editor-in-chief of JACC: Cardiovascular Interventions

    OrbusNeich releases next-generation coronary scoring balloon

    New AHA/ACC guidance released for TAVI

    Arterys receives US FDA clearance for cardio imaging analytics software

    St Jude Medical announces Merlin cybersecurity updates

    The Medicines Company announces positive 180-day results for PCSK9 inhibitor

    Few cardiologists take steps to avoid radiation exposure during pregnancy despite concerns

    CardiAMP heart failure trial initiated at two US centres

    MicroPort completes patient enrolment of VitaFlow pre-market clinical trial

    First patient enrolled in Somahulation’s CABG European registry of DuraGraft

    Abbott completes acquisition of St Jude Medical

    Transcatheter valve-in-ring implantation is feasible for reducing tricuspid regurgitation

    Patient with tricuspid regurgitation successfully treated with world’s first transcatheter tricuspid valved stent

    Medinol reports positive clinical results for Elunir elastomer-coated drug-eluting stent

    ACC releases new appropriate use criteria for coronary revascularisation

    Women fare better than men one year after transcatheter aortic valve implantation

    New ACC/AHA report outlines 10 measures for the prevention of sudden cardiac death

    Micro Interventional Devices has first-in-human success with MIA technology

    Blood troponin level could predict silent heart disease risk

    Santa is not checking his list about whether you’re naughty or nice

    US FDA bans powdered gloves

    NICE collaborates with US FDA on Payer Communication Taskforce

    DAPT

    Terumo signs to acquire St Jude Medical and Abbott’s vascular closure business

    Patients with acute coronary syndrome at increased risk of suicide

    Boston Scientific closes acquisition of certain Neovasc assets

    AngioSoma appoints new chief executive officer

    FDA pre-market approval for the Impella heart pump for high-risk PCI now includes Impella CP

    4Tech appoints Michael Ennen as president and chief executive officer

    Teleflex to acquire Vascular Solutions in US$1 billion deal

    Novel locking microcatheter could improve procedural success rates of chronic total occlusion PCI

    CADILLAC risk score could be used to identify STEMI patients for safe, early discharge

    Japan’s Ministry of Health, Labor and Welfare approves reimbursement for Medtronic’s CoreValve Evolut R system

    Boston Scientific to acquire Neovasc biological tissue capabilities

    FDA grant Cardiac Dimensions investigational device exemption approval to conduct study

    Medtronic first to receive CE mark for less-invasive HVAD implant procedure

    Toshiba receives US FDA clearances for new CT reconstruction tech and Vantage MR software

    Amsel Medical to present Occluder research at ICI 2016

    Edward Lifesciences to acquire Valtech

    Neovasc receives approval to launch European study of Tiara transcatheter mitral valve

    RSNA 2016: Siemens Healthineers debuts innovative, robot-supported ARTIS pheno angiography system

    RSNA 2016: Toshiba Medical aims to transforms CT Imaging with the Llaunch of the Aquilion ONE / GENESIS Edition

    OrbusNeich launch next generation of its Combo dual therapy stent

    CardioCel now approved for use in the UAE

    First Revivent transcatheter ventricular enhancement procedure for ischaemic cardiomyopathy performed in The Netherlands

    AHA 2016: Mount Sinai cardiologists honoured

    AHA 2016: Mortality rate with FFR-guided treatment of multivessel disease is unexpectedly high

    AHA 2016: Heparin plus tirofiban is safe and effective for use during PCI

    HeartFlow FFRct approved for use in Japan

    AHA 2016: Low-dose rivaroxaban reduces clinically significant bleeding in PCI patients with atrial fibrillation

    AHA 2016: Elizabeth M McNally wins AHA prize for research into genetic flaws responsible for inherited human disorders including heart failure

    AHA 2016: MOMENTUM 3 shows HeartMate 3 LVAD improves clinical outcomes compared with HeartMate II LVAD

    AHA 2016: Strong positive one-year data for Corvia Medical’s InterAtrial shunt device

    AHA 2016: Incomplete revascularisation after PCI increases risk of adverse events after surgery

    AHA 2016: The Medicines Company and Alnylam Pharmaceuticals present positive results from ORION-1 phase 2 study of their PCSK9 inhibitor inclisiran

    Trialign system successfully used to treat patient with tricuspid regurgitation because of a cardiac implantable electronic device lead

    AHA 2016: Two thirds of patients experience plaque regression with the PCSK9 inhibitor evolocumab

    Cardiovascular Research Foundation to launch structural heart disease journal

    Patient enrolment complete in study assessing use of dabigatran atrial fibrillation patients undergoing PCI

    Terumo to distribute STARSystem for radial access procedures in Europe

    TCT 2016: Three-year data fail to show Absorb to be superior or even non-inferior to Xience

    TCT 2016: Different endpoints may have led to different outcomes for left main PCI

    TCT 2016: Patent foramen ovale closure is more effective than medical management in preventing recurrent stroke

    Pacemaker after TAVI is associated with worse outcomes

    Pfizer discontinues the global development of its investigational PCSK9 inhibitor

    510(K) clearance for Merit Medical’s SwiftNinja steerable microcatheter

    Fresenius Medical Care acquires Xenios AG

    Svelte Medical launches DIRECT III post-market registry study

    NICE recommends dual antiplatelet therapy with ticagrelor and aspirin

    TCT 2016: Positive data for transcatheter tricuspid repair with Trialign

    TCT 2016: Transfemoral TAVI improves quality of life in intermediate-risk patients

    TCT 2016: Tiara TMVI device highlighted in presentations

    TCT 2016: CoreValve Evolut R continues to be associated with good outcomes at one year

    NICE should develop heart valve guidelines says Heart Valve Voice

    TCT 2016: “Excellent” rates of late lumen loss with Desolve bioresorbable scaffold

    TCT 2016: Cardiovascular System initiates largest ever randomised trial of coronary atherectomy for calcified lesions

    Arterys receives 510(k) clearance for its cloud-based medical image visualization and quantification software

    Charity believes NHS programme will leave hundreds of atrial fibrillation patients at risk of stroke

    TCT 2016: High implant success rates with St Jude Medical’s Amulet LAA occluder

    TCT 2016: Women and minorities have a significantly higher risk of death after PCI than white men

    TCT 2016: SENTINEL trial fails to meet overall primary efficacy endpoint but does in adjusted model

    TCT 2016: Physicians discuss their positive experiences of using a metallic scaffold

    TCT 2016: First-in-human data shows Medtronic’s drug-filled stent to be non-inferior to Resolute

    TCT 2016: Positive real-world data for CoreValve Evolut R presented

    TCT 2016: FDA approve Amplatzer PFO occluder device ahead of first report investigation presentation

    TCT 2016: All comers study finds no differences between Orsiro, Synergy and Resolute Integrity

    TCT 2016: ILUMEN III shows some advantages with OCT

    Tryton Medical enters into strategic agreement with Cardinal Health

    TCT 2016: Valtech to host symposium about mitral and tricuspid valve repair

    Promising initial results suggest smartphone app could aid detection of myocardial infarction

    CorPath GRX robotic system receives FDA 510(k) clearance

    TCT 2016: 30-day patient data from SCOUT I study to be presented

    FDA clear temporary pacing lead for use during TAVI and other cardiovascular applications

    St Jude Medical shareholders approve merger with Abbott

    FDA approval of 34mm CoreValve Evolut R means device is largest available TAVI valve in USA

    Miracor receives additional funding to expand clinical and commercial activities with the PiCSO impulse system

    TCT 2016: Philips showcases its latest suite of image guidance solutions for the minimally invasive treatment of cardiovascular disease

    Cardiac rehabilitation after acute myocardial infarction does not improve health status outcomes

    TAVI is “technically feasible” for managing aortic regurgitation in high-risk patients

    TCT 2016: CeloNova BioSciences announces key activities

    TCT 2016: Boston Scientific announces scheduled presentations

    Svelte Medical awarded CE mark for its Direct RX stent

    TCT 2016: St Jude Medical to highlight latest cardiovascular portfolio

    Adherence to medication more powerful predictor of adverse outcomes than type of revascularisation

    FDA approve clinical trial of a miniature heart assist device for infants and children

    Health Canada grants licence to Medtronic for its CoreValve Evolut R system

    Vascular Solutions receive FDA clearance for its Fluent inflation device

    TCT 2016: First live case featuring Desolve NXT scaffold to be presented

    TCT 2016: Breakfast symposium to explore robotic therapy in interventional cardiology

    UK hospital to start largest study of its kind to evaluate minimally invasive sternotomy for mitral regurgitation patients

    US FDA issues Class I recall for 8040 Leonhard Lang multifunction defibrillation electrodes

    Positive top-line results for The Medicines Company’s PCSK9si

    St. Jude Medical and Abbott to sell portion of vascular closure and electrophysiology businesses to Terumo

    TCT 2016: Tryton Medical to hold clinical symposium on treatment of complex bifurcation lesions

    St Jude Medical to form cyber security medical advisory board

    Experience matters when stenting the left main

    Suzette Jaskie appointed as vice president Global Medical Affairs at Corindus Vascular Robotics

    Twitter “may be useful” for researching how general public discuss cardiovascular disease

    Mild-to-moderate chronic kidney disease no longer associated with worse outcomes after PCI

    Prophylactic ipsilateral ulnar compression significantly reduces risk of radial artery occlusion

    BioStable Science & Engineering completes direct de novo application to FDA for an aortic annuloplasty device

    FDA approves St Jude Medical’s PressureWire X guidewire

    Ian Meredith to become global chief medical officer of Boston Scientific

    New vice president of US market development for CVRx

    Data for The Medicines Company’s PCSK9si will be presented at AHA

    FDA deems two HeartWare HVAD recalls as “Class I”

    EACTS 2016: DuraGraft vascular graft treatment improves long-term outcomes after CABG

    Two-year MAJESTIC data show sustained positive results for Eluvia drug-eluting stent

    New brain lesions are found in 94% of patients following TAVI

    EACTS 2016: Positive one-year outcomes for Medtronic’s surgical aortic valve Avalus

    EACTS2016: World’s first heart valve that “enables cardiovascular restoration” successfully implanted in three children

    New “resilient” surgical aortic valve now available in Europe

    Heart team at Zurich University Hospital use Cardioband for tricuspid repair for the first time

    Japan approves Abiomed’s Impella 2.5 and Impella 5.0 heart pumps

    Philips collaborates with World Heart Federation, launches health behaviours website

    Opsens receives 510(k) clearance for the OptoMonitor II providing extended indication

    Young women with premature acute coronary syndrome now do as well as men

    Visceral abdominal fat associated with newly-identified heart disease risk factors

    Xeltis established international clinical advisory board

    PCRLV 2016: MitraClip may be “safe and feasible” for treating tricuspid regurgitation

    PCRLV 2016: New approaches to TAVI are still being explored

    Smartphones can help to streamline hospital transfer for myocardial infarction patients

    TriGuard cerebral protection associated with significant improvements in brain protection in TAVI patients

    Load more

    Most read

    Mayra Guerrero

    Bruno Scheller

    Rafael Sádaba

    Cardiovascular News

    Write to us
    Editorial: Will Date [email protected]
    Advertising: Hannah Shiels [email protected]


    United Kingdom:

    BIBA Medical, Europe
    526 Fulham Road, Fulham, London, SW6 5NR
    TEL: +44 (0)20 7736 8788
    Email: [email protected]

    United States:

    BIBA Medical, North America
    155 North Wacker Drive, Suite 4250, Chicago, IL 60606
    TEL: +1 949 723 9309
    Email: [email protected]

    Terms and Conditions | Privacy Policy

    Facebook Linkedin Mail Twitter Youtube